Literature DB >> 33364734

Validity of the Glasgow prognostic score and modified systemic inflamma-tion score in predicting complicated cholecystitis.

D O Karakaş1, M Yeşiltaş1.   

Abstract

BACKGROUND: Complicated cholecystitis (CC) is the severe form of acute cholecystitis (AC). Clinical, radiological, inflammatory, or biochemical parameters are used to predict presence of CC. We aimed to evaluate the Glasgow prognostic (GPS) and modified systemic inflammation scores (mSIS) that are used to predict presence of CC.
METHODS: We retrospectively analyzed data from patients who underwent AC surgery from January 2014 to August 2019. Collected information included age, gender, length of stay (LOS), pathology [as CC or uncomplicated (UCC)], albumin, C-reactive protein (CRP), white blood cells (WBC), and neutrophils (NEU) results. The lymphocyte-to-monocyte ratio (LMR) was calculated. The GPS was calculated using CRP and albumin levels, and mSIS was calculated using LMR and albumin levels, and it was scored from 0 to 2.
RESULTS: Among the 593 hospitalized patients, 217 patients underwent AC surgery and were included in the study. Among them, 40.1 % of the patients had CC, 53.4 % were male, and the mean age was 51.76 ± 13.8 years. LOS was significantly longer for CC compared to UCC (p =0.018). Four patients died from CC (1.8 %). The mean CRP, WBC, and NEU levels were not different CC compared to UCC (p =0.821, p =0.84, and p =0.196, respectively). The cut-off values for CC were 103.54 mg/L, 15.18 ×106/μL, and 11.79 ×103/μL, respectively. GPS and mSIS were significantly higher in CC compared to UCC (p =0.008, p =0.022, respectively).
CONCLUSION: CRP, WBC, and NEU could be used to predict presence of CC. The combination of CRP or LMR with albumin could be a positive but weak predictor of CC, and it is quick, easy to use, and reliable. HIPPOKRATIA 2020, 24(1): 15-20. Copyright 2020, Hippokratio General Hospital of Thessaloniki.

Entities:  

Keywords:  Acute cholecystitis; Glasgow prognostic score; complicated cholecystitis; modified systemic inflammation score; severity

Year:  2020        PMID: 33364734      PMCID: PMC7733360     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  22 in total

1.  Role of Procalcitonin in Evaluation of the Severity of Acute Cholecystitis.

Authors:  Yucel Yuzbasioglu; Hikmet Duymaz; Ceren Sen Tanrikulu; Huseyin Cahit Halhalli; Mirac Ozturk Koc; Meral Tandoğan; Figen Coskun
Journal:  Eurasian J Med       Date:  2016-10

Review 2.  Acute-phase proteins and other systemic responses to inflammation.

Authors:  C Gabay; I Kushner
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

3.  Predicting gangrenous cholecystitis.

Authors:  Bin Wu; Thomas J Buddensick; Hamid Ferdosi; Dusty Marie Narducci; Amanda Sautter; Lisa Setiawan; Haroon Shaukat; Mustafa Siddique; Gisela N Sulkowski; Farin Kamangar; Gopal C Kowdley; Steven C Cunningham
Journal:  HPB (Oxford)       Date:  2014-03-17       Impact factor: 3.647

Review 4.  Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis.

Authors:  Tomohiro F Nishijima; Hyman B Muss; Shlomit S Shachar; Kazuo Tamura; Yasushi Takamatsu
Journal:  Cancer Treat Rev       Date:  2015-10-23       Impact factor: 12.111

5.  Can red cell distribution width be used as a predictor of acute cholecystitis?

Authors:  İlker Murat Arer; Hakan Yabanoğlu; Kenan Çalışkan
Journal:  Turk J Surg       Date:  2017-06-01

6.  Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma.

Authors:  Qun-Xiong Pan; Zi-Jian Su; Jian-Hua Zhang; Chong-Ren Wang; Shao-Ying Ke
Journal:  Mol Clin Oncol       Date:  2017-02-16

Review 7.  The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: a literature review.

Authors:  Yongyin Gao; Dingzhi Huang
Journal:  J Cancer Res Ther       Date:  2014 Oct-Dec       Impact factor: 1.805

8.  Clinical characteristics of acute cholecystitis with elevated liver enzymes not associated with choledocholithiasis.

Authors:  Sang Hee Song; Chang-Il Kwon; Sun Mi Jin; Hyun Jung Park; Chul Woon Chung; Sung Won Kwon; Kwang Hyun Ko; Sung Pyo Hong
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-04       Impact factor: 2.566

9.  Use of a predictive equation for diagnosis of acute gangrenous cholecystitis.

Authors:  Liz Nguyen; Shawn P Fagan; Timothy C Lee; Nori Aoki; Kamal M F Itani; David H Berger; Samir S Awad
Journal:  Am J Surg       Date:  2004-11       Impact factor: 2.565

10.  Does the Tokyo guidelines predict the extent of gallbladder inflammation in patients with acute cholecystitis? A single center retrospective analysis.

Authors:  Peter C Ambe; Hildegard Christ; Dirk Wassenberg
Journal:  BMC Gastroenterol       Date:  2015-10-20       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.